It is reported that the level of RASSF1A promoter hypermethylation in sputum and bronchial fluid is significantly higher among smokers compared to non-smokers, contributing to an increased incidence of lung cancer (35, 36). This evidence concerns the gene RASSF1 and lung cancer.